1. Calvert US Select Equity ETF (CVSE) is slated for liquidation. 2. Liquidation date is scheduled for October 20, 2025. 3. Shareholders can sell shares until October 14, 2025. 4. Post-liquidation, trading of CVSE shares will cease. 5. Tax implications will affect shareholders upon liquidation.
The liquidation of CVSE directly indicates a negative outlook, similar to past fund closures that resulted in significant stock price declines.
The announcement of liquidation significantly alters the operational nature of CVSE, making it highly relevant for current and future investors.
Long-term implications arise from reduced investor confidence and potential impact on similar funds in the future.
Morgan Stanley Investment Management, Inc. today announced the upcoming liquidation of Calvert US Select Equity ETF (CVSE) (the "Fund"), a series of Morgan Stanley ETF Trust (the "Trust"). The Board of the Trust approved a Plan of Liquidation with respect to the Fund. Pursuant to the Plan of Liquidation, the assets of the Fund will be liquidated, known or reasonably ascertainable liabilities of the Fund will be satisfied or provided for, the remaining proceeds will be distributed to the Fund's shareholders and all of the issued and outstanding shares of the Fund will be redeemed (the "Liquidation"). The Liquidation is expected to occur on or about October 20, 2025 (the "Liquidation Date").
Effective upon the close of business on October 14, 2025, the Fund will no longer accept orders for the purchase of Creation Units. This is also expected to be the Fund's last full day of trading on NYSE Arca, Inc. ("NYSE Arca"). Shareholders may sell their shares of the Fund on NYSE Arca until market close on October 14, 2025 (at which point NYSE Arca is expected to halt trading in shares of the Fund) or remain invested in the Fund. In addition, during the time between market close on October 14, 2025 and the Liquidation Date, because the Fund's shares will not be traded on NYSE Arca, shareholders will be unable to sell their shares on NYSE Arca and there can be no assurance that there will be a market for the purchase or sale of the Fund's shares.
Prior to the Liquidation Date, the Fund will engage in business activities for the purpose of winding up the Fund's business and affairs and transitioning the Fund's assets to cash and cash equivalents in preparation for the orderly liquidation and subsequent distribution of proceeds to remaining shareholders as of the close of business on the Liquidation Date. During this transition period, the Fund may no longer be pursuing its investment objective or be managed consistent with its stated investment strategies. This is likely to impact the Fund's performance.
Prior to the Liquidation Date, shareholders of the Fund may sell their shares of the Fund on NYSE Arca until market close on October 14, 2025 (and may incur typical transaction fees from their broker-dealer) or remain invested in the Fund. In addition, prior to the Liquidation Date, authorized participants may continue to submit orders to the Fund for the redemption of Creation Units in the manner described in the Fund's prospectus. Shareholders that continue to hold shares of the Fund on the Liquidation Date will receive a liquidating distribution that may be in an amount that is greater or less than the amount a shareholder might receive if they dispose of their shares on NYSE Arca prior to market close on October 14, 2025. Additionally, shareholders who remain invested in the Fund may bear increased brokerage and other transaction expenses relating to the sale of portfolio investments prior to the Liquidation Date.
Unless shares of the Fund are held in a tax-deferred account, the sale or liquidation of shares held by a shareholder will generally be considered a taxable event. A shareholder should consult their personal tax adviser concerning their particular tax situation. A shareholder who owns Fund shares in a tax-deferred account, such as an individual retirement account, 401(k) or 403(b) account, should consult a tax adviser regarding the tax consequences applicable to the sale of Fund shares or the reinvestment of the proceeds of the liquidating distribution.
About Morgan Stanley Investment Management
Morgan Stanley Investment Management, together with its investment advisory affiliates, has more than 1,300 investment professionals around the world and $1.7 trillion in assets under management or supervision as of June 30, 2025. Morgan Stanley Investment Management strives to provide outstanding long-term investment performance, service, and a comprehensive suite of investment management solutions to a diverse client base, which includes governments, institutions, corporations and individuals worldwide. For further information about Morgan Stanley Investment Management, please visit www.morganstanley.com/im.
About Morgan Stanley
Morgan Stanley (NYSE:MS) is a leading global financial services firm providing a wide range of investment banking, securities, wealth management and investment management services. With offices in 42 countries, the Firm's employees serve clients worldwide including corporations, governments, institutions and individuals. For more information about Morgan Stanley, please visit www.morganstanley.com.
The Fund is distributed by Foreside Fund Services, LLC.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful under the securities laws of any such state.
Investing involves risk and it is possible to lose money on any investment in the Fund.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250919638414/en/
Colleen McElhinney
617.672.8995
Colleen.McElhinney@morganstanley.com